Clinical trial
THE ENLIGHTEN STUDY
NCT03261453
Study timeline
Study start (actual)2018-02-01Date precision: day
Registry last updated2024-02-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityverified · MONDO: obesity disorder
Overweightunresolved
Interventions
Active Elipse DeviceDEVICE
Elipse Sham DeviceDEVICE
Sponsors & collaborators
Allurion Technologieslead sponsor
Mapped research locations
New YorkNew York, United States1NashvilleTennessee, United States1PittsburghPennsylvania, United States1AuroraColorado, United States1MemphisTennessee, United States1ScottsdaleArizona, United States1CharlottesvilleVirginia, United States1ChattanoogaTennessee, United States1MetairieLouisiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03261453 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.